Tag: e-mail

NEW YORK und MAINZ, Deutschland, 25. Juli 2025 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass der Ausschuss für Humanarzneimittel (Committee for Medicinal Products for Human Use, „CHMP“) der Europäischen Arzneimittel-Agentur (European Medicines Agency, „EMA“) eine positive Beurteilung für die Marktzulassung (Marketing Authorization) des an LP.8.1 angepassten monovalenten COVID-19-Impfstoffs (COMIRNATY^® LP.8.1) der Unternehmen für die aktive Immunisierung zur Vorbeugung von COVID-19 verursacht durch SARS-CoV-2 bei Personen ab 6 Monaten ausgesprochen hat. Die Anpassung basiert auf der Empfehlung der Notfall-Taskforce (Emergency Task Force, „ETF“) der EMA, die vorschlägt, COVID-19-Impfstoffe zu aktualisieren, um die LP.8.1-Variante für die Impfkampagne 2025-2026 abzudecken. Die Notfall-Taskforce erklärte: „Eine Anpassung an LP.8.1 wird dabei helfen, die Wirksamkeit der Impfstoffe gegen das sich fortlaufend weiterentwickelnde SARS-CoV-2 aufrechtzuerhalten.“² 

Tallinna Vesi kutsub aktsionäre, investoreid, analüütikuid ja teisi huvilisi osalema ettevõtte 2025. aasta teise kvartali ja kuue kuu tulemusi tutvustaval veebiseminaril 1. augustil 2025 kell 11.00. Veebiseminar toimub inglise keeles. Tulemusi tutvustavad AS Tallinna Vesi tegevjuht Aleksandr Timofejev ja finantsdirektor Taavi Gröön.

Press release
Embargo until 25 July 2025 at 6:50 am
 Regulated information – Inside information

Persbericht
Embargo tot 25 juli 2025 om 6.50 u.
 Gereglementeerde informatie – Voorwetenschap

Communiqué de presse
Embargo jusqu'au 25 juillet 2025 à 6h50
 Information réglementée – informations confidentielles

The Unimot Group plans to enter the defence sector through a capital investment in the newly established company PZL Defence, which will specialise in the development and production of unmanned aerial vehicles (UAVs) and anti-drone systems. The project will be implemented in cooperation with PZL Sędziszów, an experienced manufacturer of components for the defence industry, and a Ukrainian partner with practical expertise gained in wartime conditions.

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all persons or entities who purchased the securities of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”).

HOUSTON, July 23, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today reported results for the second quarter ended June 30, 2025 and updated its full year 2025 Outlook, as reflected in the table below.

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) --

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Eastern Michigan Financial Corporation (OTCMKTS: EFIN) related to its merger with Mercantile Bank Corporation. Upon completion of the proposed transaction, each outstanding share of Eastern Michigan common stock will be converted into the right to receive $32.32 in cash and 0.7116 shares of Mercantile common stock. Is it a fair deal?